9/10/2024China Opens Doors to Foreign Investment in Cell Therapy and Wholly For...

9/9/2024Akeso, Summit's PD-1 Bispecific Beats Merck's Keytruda in China-Only S...

9/9/2024JIXING Announces Positive Results from Phase 3 JX02002 Trial of Etripa...

9/9/2024CDE Solicits Comments on Draft of the Q&As on Pharmaceutical Similarit...

9/9/2024China Eases Foreign Investment Restrictions on Manufacturing, Healthc...

9/9/2024House Passes BIOSECURE Act, Targeting Chinese Biotech Companies

9/6/2024Recent Executive Moves

9/5/2024Biotheus Launches Phase 1/2 Trial for PM8002 and PM1009 Combo in Metas...

9/5/2024A Share-listed MedPharm Cos Report H1/2024 Performance

9/5/2024CSL Disposes Wuhan Plasma Collection and Fractionation Operations

9/5/2024China Detains Five AstraZeneca Employees for 'Data Privacy' Breach an...

9/5/2024China to Waive Import Tariffs on Drugs and Medical Devices in Hainan's...

9/4/2024EpimAb and Vignette Enter Strategic Deal to Develop BCMA×CD3 bsAb

9/4/2024Innovent Granted U.S. Fast Track Designation for Advanced Melanoma Mo...

9/4/2024China Issues New Guidelines to Improve Rural Public Health

9/4/2024Acceleration in China+1 trend in Pharmaceuticals Sector! (HDFC)

9/3/2024Simcere Zaiming Collaborates with TargetRx to introduce A Third-genera...

9/2/2024Navigator Medicines Announces $100M Series A Financing and In-Licensin...

8/30/2024HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...

8/30/2024NMPA Suspends Import, Sales and Use of Dr. Reddy's Atomoxetine Hcl Cap...

8/30/2024Recent Executive Moves

8/30/2024Regional Price Differences of Medical Services: Evidence from China (B...

8/29/2024CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...

8/28/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...

8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

8/28/2024Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...

8/27/2024NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...

8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...

8/27/2024Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab

8/27/2024China Proposed New Anti-Monopoly Guidelines for the Pharmaceutical Sec...

Page:24/359 Total number of articles:10756: [First][<<] [22] [23] [24] [25] [26] [>>] [End]